Literature DB >> 27696218

Analgesic Drug Prescription Patterns on Five International Paediatric Wards.

Sebastian Botzenhardt1, Asia N Rashed2,3, Ian C K Wong4,5, Stephen Tomlin2,3, Antje Neubert6.   

Abstract

AIM: Analgesic and anti-inflammatory drugs are frequently prescribed in paediatrics. Prescribing and dosing patterns in hospitalised children are not well known. This study explores analgesic drug utilisation on five paediatric wards and discusses its findings in comparison with World Health Organization (WHO) guidelines.
METHOD: A sub-analysis of a prospective, multicentre, observational cohort study was undertaken. Prescription data of children aged up to ≤18 years were collected between October 2008 and December 2009 on paediatric general medical wards in five hospitals in Australia, Germany, the United Kingdom (UK), Hong Kong (HK) and Malaysia. Analgesic drug prescriptions were analysed for prescribing patterns in terms of dosing, frequency and route of administration. Dosing data were compared with local recommendations and WHO guidelines for children.
RESULTS: In the study cohort, 56.8 % (726/1278) of paediatric patients received at least one analgesic drug prescription (1227 prescriptions). The median age of patients with analgesics was 2.2 years [interquartile range (IQR) 0.8-7.3], and the median number of prescriptions per patient was one (IQR 1-2). The most commonly prescribed drugs were oral paracetamol (45.9 %, 563/1227) and oral ibuprofen (19.9 %, 244/1227). Daily doses of paracetamol ranged from 30 mg/kg/day in Germany to 67-68 mg/kg/day in the UK and HK (p < 0.05). For ibuprofen, single doses ranged from 5-6 mg/kg in HK and the UK to 10 mg/kg in Germany and Australia (p < 0.001). Opioid use prevalence was statistically different between the centres and ranged from 0 to 17.6 % (p < 0.001).
CONCLUSION: This study provides a comprehensive overview of analgesic drug use of hospitalised children. Similar to primary care data, paracetamol is the most commonly used analgesic. As recommended by WHO guidelines, oral medication was favoured and opioids used in addition to paracetamol and ibuprofen. Overall drug utilisation was in line with local recommendations and WHO guidelines. Differences in use of paracetamol and ibuprofen among countries were seen, indicating that safety concerns are perceived differently. More large-scale safety studies are needed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27696218     DOI: 10.1007/s40272-016-0198-9

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  30 in total

1.  Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study.

Authors:  Asia N Rashed; Ian C K Wong; Noel Cranswick; Stephen Tomlin; Wolfgang Rascher; Antje Neubert
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

Review 2.  Analgesics for the treatment of pain in children.

Authors:  Charles B Berde; Navil F Sethna
Journal:  N Engl J Med       Date:  2002-10-03       Impact factor: 91.245

3.  Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports.

Authors:  Lea S Blaser; Alexandra Tramonti; Pascal Egger; Manuel Haschke; Stephan Krähenbühl; Alexandra E Rätz Bravo
Journal:  Eur J Clin Pharmacol       Date:  2014-11-18       Impact factor: 2.953

4.  Alternating acetaminophen and ibuprofen for pain in children.

Authors:  Christine Smith; Ran D Goldman
Journal:  Can Fam Physician       Date:  2012-06       Impact factor: 3.275

5.  Adverse Drug Reactions in Children--International Surveillance and Evaluation (ADVISE): a multicentre cohort study.

Authors:  Asia N Rashed; Ian C K Wong; Noel Cranswick; Barbara Hefele; Stephen Tomlin; John Jackman; Kenneth Lee; Kam-Lun E Hon; Jeffrey Ong; Maisoon Ghaleb; Siew Siang Chua; Tea Ming Hui; Wolfgang Rascher; Antje Neubert
Journal:  Drug Saf       Date:  2012-06-01       Impact factor: 5.606

Review 6.  Tramadol can selectively manage moderate pain in children following European advice limiting codeine use.

Authors:  Pierluigi Marzuillo; Lorenzo Calligaris; Egidio Barbi
Journal:  Acta Paediatr       Date:  2014-08-02       Impact factor: 2.299

7.  Effect of neonatal circumcision on pain response during subsequent routine vaccination.

Authors:  A Taddio; J Katz; A L Ilersich; G Koren
Journal:  Lancet       Date:  1997-03-01       Impact factor: 79.321

8.  Pain in hospitalized pediatric patients: how are we doing?

Authors:  Jacqueline A Ellis; Barbara Virley O'Connor; Mario Cappelli; John T Goodman; Renee Blouin; Craig W Reid
Journal:  Clin J Pain       Date:  2002 Jul-Aug       Impact factor: 3.442

9.  Pain assessment and intensity in hospitalized children in Canada.

Authors:  Bonnie J Stevens; Denise Harrison; Judy Rashotte; Janet Yamada; Laura K Abbott; Geraldine Coburn; Jennifer Stinson; Sylvie Le May
Journal:  J Pain       Date:  2012-09       Impact factor: 5.820

10.  Drug use in children: cohort study in three European countries.

Authors:  Miriam C J M Sturkenboom; Katia M C Verhamme; Alfredo Nicolosi; Macey L Murray; Antje Neubert; Daan Caudri; Gino Picelli; Elif Fatma Sen; Carlo Giaquinto; Luigi Cantarutti; Paola Baiardi; Maria-Grazia Felisi; Adriana Ceci; Ian C K Wong
Journal:  BMJ       Date:  2008-11-24
View more
  3 in total

1.  Opioid e-prescribing trends at discharge in a large pediatric health system.

Authors:  Christopher M Horvat; Brian Martin; Liwen Wu; Anthony Fabio; Phil E Empey; Fanuel Hagos; Sheila Bigelow; Sajel Kantawala; Alicia K Au; Patrick M Kochanek; Robert S B Clark
Journal:  J Opioid Manag       Date:  2019 Mar/Apr

2.  Prescribing of Nonsteroidal Anti-inflammatory Drugs, Tramadol, and Opioids in Children: Patterns of Its Utilization.

Authors:  Che Suraya Zin
Journal:  J Pharm Bioallied Sci       Date:  2020-11-05

3.  Metamizole Use in Children: Analysis of Drug Utilisation and Adverse Drug Reactions at a German University Hospital between 2015 and 2020.

Authors:  Julia Zahn; Sonja Eberl; Wolfgang Rödle; Wolfgang Rascher; Antje Neubert; Irmgard Toni
Journal:  Paediatr Drugs       Date:  2021-12-08       Impact factor: 3.022

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.